The import of insulin not in dosage forms to France is expected to exhibit a gradual declining trend from 2024 to 2028. The forecasted data reveals a slight year-on-year decrease, with values dropping from 3.05 thousand kilograms in 2024 to 2.88 thousand kilograms in 2028. This trend indicates a compound annual growth rate (CAGR) of approximately -1.45% over this period, suggesting a consistent reduction in imports.
Trends to watch for in the future include changes in domestic insulin production capabilities, evolving healthcare policies impacting insulin imports, and technological advancements that may affect the importation of insulin in bulk form. Additionally, shifts in demand due to demographic changes or breakthroughs in diabetes treatment alternatives could further influence these import trends.
